Apyx Medical Current Ratio 2010-2025 | APYX
Apyx Medical current ratio from 2010 to 2025. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
| Apyx Medical Current Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets | Current Liabilities | Current Ratio |
| 2025-03-31 | $0.05B | $0.01B | 5.45 |
| 2024-12-31 | $0.06B | $0.01B | 5.26 |
| 2024-09-30 | $0.05B | $0.01B | 5.46 |
| 2024-06-30 | $0.06B | $0.01B | 5.33 |
| 2024-03-31 | $0.06B | $0.01B | 5.87 |
| 2023-12-31 | $0.07B | $0.01B | 5.52 |
| 2023-09-30 | $0.05B | $0.01B | 4.87 |
| 2023-06-30 | $0.05B | $0.02B | 2.78 |
| 2023-03-31 | $0.05B | $0.02B | 2.84 |
| 2022-12-31 | $0.04B | $0.01B | 3.63 |
| 2022-09-30 | $0.05B | $0.01B | 4.14 |
| 2022-06-30 | $0.05B | $0.01B | 4.45 |
| 2022-03-31 | $0.06B | $0.01B | 4.72 |
| 2021-12-31 | $0.06B | $0.01B | 4.60 |
| 2021-09-30 | $0.06B | $0.01B | 5.11 |
| 2021-06-30 | $0.06B | $0.01B | 5.73 |
| 2021-03-31 | $0.06B | $0.01B | 6.48 |
| 2020-12-31 | $0.07B | $0.01B | 7.22 |
| 2020-09-30 | $0.07B | $0.01B | 7.05 |
| 2020-06-30 | $0.07B | $0.01B | 7.25 |
| 2020-03-31 | $0.07B | $0.01B | 7.00 |
| 2019-12-31 | $0.08B | $0.01B | 6.23 |
| 2019-09-30 | $0.08B | $0.01B | 8.73 |
| 2019-06-30 | $0.08B | $0.01B | 10.38 |
| 2019-03-31 | $0.09B | $0.01B | 9.90 |
| 2018-12-31 | $0.09B | $0.01B | 10.43 |
| 2018-09-30 | $0.11B | $0.02B | 4.77 |
| 2018-06-30 | $0.02B | $0.01B | 3.56 |
| 2018-03-31 | $0.02B | $0.01B | 3.82 |
| 2017-12-31 | $0.02B | $0.01B | 3.78 |
| 2017-09-30 | $0.02B | $0.01B | 4.63 |
| 2017-06-30 | $0.02B | $0.01B | 4.29 |
| 2017-03-31 | $0.03B | $0.01B | 5.00 |
| 2016-12-31 | $0.03B | $0.01B | 5.03 |
| 2016-09-30 | $0.02B | $0.00B | 4.85 |
| 2016-06-30 | $0.02B | $0.01B | 4.46 |
| 2016-03-31 | $0.02B | $0.01B | 2.85 |
| 2015-12-31 | $0.02B | $0.00B | 5.35 |
| 2015-09-30 | $0.02B | $0.01B | 5.08 |
| 2015-06-30 | $0.03B | $0.00B | 6.38 |
| 2015-03-31 | $0.03B | $0.00B | 6.15 |
| 2014-12-31 | $0.02B | $0.00B | 4.08 |
| 2014-09-30 | $0.02B | $0.00B | 5.25 |
| 2014-06-30 | $0.02B | $0.00B | 7.13 |
| 2014-03-31 | $0.02B | $0.00B | 8.00 |
| 2013-12-31 | $0.02B | $0.00B | 6.81 |
| 2013-09-30 | $0.02B | $0.00B | 4.59 |
| 2013-06-30 | $0.02B | $0.01B | 2.40 |
| 2013-03-31 | $0.02B | $0.00B | 7.10 |
| 2012-12-31 | $0.02B | $0.00B | 8.45 |
| 2012-09-30 | $0.02B | $0.00B | 8.47 |
| 2012-06-30 | $0.02B | $0.00B | 8.23 |
| 2012-03-31 | $0.02B | $0.00B | 8.15 |
| 2011-12-31 | $0.02B | $0.00B | 6.90 |
| 2011-09-30 | $0.02B | $0.00B | 8.39 |
| 2011-06-30 | $0.02B | $0.00B | 8.19 |
| 2011-03-31 | $0.02B | $0.00B | 7.35 |
| 2010-12-31 | $0.02B | $0.00B | 8.26 |
| 2010-09-30 | $0.02B | $0.00B | 6.70 |
| 2010-06-30 | $0.02B | $0.00B | 7.41 |
| 2010-03-31 | $0.01B | $0.00B | 4.79 |
| 2009-12-31 | $0.01B | $0.00B | 5.34 |
| 2009-09-30 | $0.01B | $0.00B | 4.27 |
| 2009-06-30 | $0.01B | $0.00B | 3.90 |
| 2009-03-31 | $0.01B | $0.00B | 4.83 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.085B | $0.048B |
| Apyx Medical Corporation is an energy technology company. It provides products in the cosmetic and surgical markets. The company's Helium Plasma Technology is marketed and sold as Renuvion(R) in the cosmetic surgery market and J-Plasma(R) in the hospital surgical market. Apyx Medical Corporation, formerly known as Bovie Medical Corporation, is based in FL, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $215.166B | 25.24 |
| Boston Scientific (BSX) | United States | $153.330B | 38.39 |
| Stryker (SYK) | United States | $148.630B | 31.08 |
| EssilorLuxottica (ESLOY) | France | $131.070B | 0.00 |
| Medtronic (MDT) | Ireland | $114.929B | 16.29 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.764B | 0.00 |
| Haleon (HLN) | United Kingdom | $43.126B | 24.62 |
| ResMed (RMD) | United States | $37.818B | 28.41 |
| GE HealthCare Technologies (GEHC) | United States | $34.781B | 16.51 |
| Agilent Technologies (A) | United States | $32.381B | 21.11 |
| Terumo (TRUMY) | Japan | $23.911B | 31.06 |
| Koninklijke Philips (PHG) | Netherlands | $23.688B | 16.62 |
| Insulet (PODD) | United States | $20.003B | 78.52 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.437B | 11.84 |
| Baxter (BAX) | United States | $14.251B | 10.64 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.214B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $10.417B | 0.00 |
| Demant (WILYY) | Denmark | $8.633B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.705B | 23.33 |
| Lantheus Holdings (LNTH) | United States | $4.855B | 12.25 |
| Prestige Consumer Healthcare (PBH) | United States | $3.744B | 16.73 |
| Perrigo (PRGO) | Ireland | $3.706B | 9.39 |
| Haemonetics (HAE) | United States | $3.485B | 15.88 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.307B | 27.48 |
| ICU Medical (ICUI) | United States | $3.014B | 22.23 |
| LeMaitre Vascular (LMAT) | United States | $1.802B | 40.29 |
| QuidelOrtho (QDEL) | United States | $1.721B | 11.84 |
| AtriCure (ATRC) | United States | $1.449B | 0.00 |
| Acuren (TIC) | United States | $1.408B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.244B | 12.63 |
| Phibro Animal Health (PAHC) | United States | $1.192B | 15.24 |
| Green Thumb Industries (GTBIF) | United States | $1.190B | 26.76 |
| Neogen (NEOG) | United States | $1.029B | 13.17 |
| BioLife Solutions (BLFS) | United States | $0.996B | 0.00 |
| InMode (INMD) | Israel | $0.878B | 8.85 |
| Kestra Medical Technologies (KMTS) | United States | $0.816B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.670B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.625B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.619B | 0.00 |
| Owens & Minor (OMI) | United States | $0.599B | 4.97 |
| Evolus (EOLS) | United States | $0.593B | 0.00 |
| CeriBell (CBLL) | United States | $0.563B | 0.00 |
| Valneva SE (VALN) | France | $0.557B | 0.00 |
| Surmodics (SRDX) | United States | $0.432B | 0.00 |
| SNDL (SNDL) | Canada | $0.405B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.336B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.315B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.314B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.298B | 10.97 |
| Quanterix (QTRX) | United States | $0.268B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.267B | 0.00 |
| Cerus (CERS) | United States | $0.260B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.257B | 21.63 |
| Aurora Cannabis (ACB) | Canada | $0.255B | 75.50 |
| OraSure Technologies (OSUR) | United States | $0.239B | 0.00 |
| ZimVie (ZIMV) | United States | $0.235B | 10.68 |
| Sanara MedTech (SMTI) | United States | $0.234B | 0.00 |
| Brainsway (BWAY) | Israel | $0.228B | 60.45 |
| Biote (BTMD) | United States | $0.220B | 6.18 |
| Canopy Growth (CGC) | Canada | $0.200B | 0.00 |
| High Tide (HITI) | Canada | $0.199B | 0.00 |
| Omeros (OMER) | United States | $0.197B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.195B | 0.00 |
| Organigram Global (OGI) | Canada | $0.194B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.180B | 14.69 |
| TriSalus Life Sciences (TLSI) | United States | $0.174B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.149B | 0.00 |
| Exagen (XGN) | United States | $0.149B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.120B | 14.73 |
| TerrAscend (TSNDF) | Canada | $0.110B | 0.00 |
| Jin Medical (ZJYL) | China | $0.103B | 0.00 |
| Fonar (FONR) | United States | $0.099B | 12.80 |
| MacroGenics (MGNX) | United States | $0.093B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.091B | 0.00 |
| Veru (VERU) | United States | $0.087B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.087B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.076B | 0.00 |
| Zynex (ZYXI) | United States | $0.070B | 0.00 |
| Agape ATP (ATPC) | $0.065B | 0.00 | |
| Cytosorbents (CTSO) | United States | $0.064B | 0.00 |
| ImmuCell (ICCC) | United States | $0.060B | 0.00 |
| Safety Shot (SHOT) | United States | $0.055B | 0.00 |
| United-Guardian (UG) | United States | $0.042B | 14.52 |
| Nephros (NEPH) | United States | $0.039B | 52.07 |
| Rockwell Medical (RMTI) | United States | $0.038B | 0.00 |
| Modular Medical (MODD) | United States | $0.037B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.023B | 0.00 |
| INLIF (INLF) | $0.015B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.014B | 0.00 |
| Flora Growth (FLGC) | United States | $0.014B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.014B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.013B | 0.00 |
| Senestech (SNES) | United States | $0.010B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| Sharps Technology (STSS) | United States | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |